Association between Ambient Air Pollution and Diabetes Mellitus in Europe and North America: Systematic Review and Meta-Analysis

1Ambient air pollution ranks high among risk factors for the global burden of disease, and is linked to several chronic noncommunicable conditions such as cardiovascular diseases, asthma, chronic obstructive pulmonary diseases (COPD), and cancers including lung, cervical, and brain cancers. Persons with type 2 diabetes mellitus (T2DM) are at increased risk to develop micro- and macrovascular diseases and reduced lung function. Air pollution has also been shown to be more detrimental to diabetic patients, worsening their clinical outcomes.

2More recent evidence is supportive of an air pollution effect on diabetes risk. Experimental evidence show that possible pathways may include endothelial dysfunction, overactivity of the sympathetic nervous system, immune response alterations in visceral adipose tissues; endoplasmic reticulum stress resulting in alterations in insulin transduction, insulin sensitivity, and glucose metabolism; and alterations in mitochondria and brown adipocytes.

3systematically reviewed the etiologic association between environmental pollution and diabetes, taking into account studies on organic pollutants and secondary effects of air pollution on diabetic patients published up to November 2010. They described a positive association between environmental pollution and prevalent diabetes, as well as increased morbidity and mortality among diabetic patients. A number of pertinent studies have been published since this review, and thus far there is, to the best of our knowledge, no meta-analysis of the available evidence. We therefore systematically identified and reviewed the epidemiological evidence on the association between air pollution and diabetes mellitus, and synthesized the results of studies on the association with T2DM.

4Search strategy. We systematically searched electronic literature databases [MEDLINE (http://www.nlm.nih.gov/bsd/pmresources.html), EMBASE (https://www.embase.com), and ISI Web of Science (http://www.webofknowledge.com)] for pertinent literature published up to 3 February 2014. Terms used in this search included “air pollution,” “air pollutants,” “particulate matter,” “PM10,” “PM2.5,” “nitrogen dioxide,” “NO2,” “NOx,” “ozone,” “soot,” “smog,” “diabetes mellitus,” “diabetes,” “T1DM,” “T2DM,” “type 1 DM,” “type 2 DM,” “IDDM,” “NIDDM,” alone and in combination. We applied no filters for study designs. Reference lists of eligible articles were searched for further pertinent articles. After de-duplication, titles and abstracts were screened for eligibility and potentially relevant articles were retrieved as full texts. Screening was performed independently by two reviewers and any discrepancies were resolved by discussion.

5Inclusion and exclusion criteria. We included only original research published in English as a full publication in a peer-reviewed journal. We accepted any type of study design. In eligible studies, the definition of air pollution and diabetes mellitus had to be clearly stated. Air pollution had to be outdoor (ambient, including traffic-related), and we accepted any type of assessment including particle concentration in the air or indicators of long-term traffic exposure. Diabetes mellitus had to be physician diagnosed or based on the use of antidiabetic medications. We included any type of diabetes mellitus (type 1, type 2, and gestational). Eligible studies had to report quantitative measures of association between air pollution and diabetes mellitus, and their 95% confidence intervals (CIs) (or enough data to allow derivation of this association). We excluded studies that were based on the effect of blood markers, and not clearly defining clinical outcomes. Studies testing only whether diabetes status would modify the association between air pollution and health outcomes were not considered in this review. Animal studies were excluded.

6For the meta-analysis, only studies on individual type 2 diabetes risk were included. We included all studies that quantified particle concentrations as “per... μg/m3” or “ppb.” If the diabetes type was not clearly stated, we considered diagnoses of diabetes in nonpregnant adults (≥ 18 years age) as diagnoses of T2DM because > 90% of new diagnoses of adult diabetes is type 2 diabetes.

7Data extraction. We extracted the following data from the eligible studies: year of study, study setting, study design, year of publication, population demographics, study definition of diabetes and assessment of air pollution exposure, confounder adjustments, and effect modification assessments. We extracted data on the effect estimates (unadjusted and final model) of the association (and their 95% CIs) between air pollution and diabetes.

8Data were extracted independently by two reviewers and disagreements were resolved by discussion.

9Meta-analysis. We used random-effects models to synthesize the associations between air pollution and T2DM. Random-effect models give more weight to smaller studies and have typically wider CIs because in addition to the within-study variance, they also consider potential variation between the true effects that all included studies estimate. We used fixed-effects models (which assume that all studies share a common true effect) in a sensitivity analysis.

10We used risk ratios as measure of association across all studies. When hazard ratios and incidence risk ratios were reported, we directly considered them as risk ratios. Because diabetes is not very common, we considered reported odds ratios as equivalent to risk ratios. For studies with estimates of association from multiple particle concentration sources, we chose the estimates modelled at participants’ residences (land-use regression, kriging, or satellite-based estimates). We used the effect estimates reported by the study authors as “main model” or “fully adjusted model.” We used estimates of association and their standard errors reported as “per 10 μg/m3” of exposure and we converted other reported quantities or units where necessary.

11We described the between-study heterogeneity using the I2 metric and the between-studies’ variance using Tau2. We assessed publication bias using the Egger’s test for asymmetry. We conducted sensitivity analyses including only studies that a) measured air pollution exposure before DM diagnosis, b) comprised both males and females, and c) were longitudinal, and we applied a fixed-effects analysis. All analyses were performed with Stata version 12 (StataCorp, College Station, TX, USA) using the “metan” command. p-Values were two-tailed and p < 0.05 was considered nominally statistically significant.

12For reporting, we followed the Meta-analysis Of Observational Studies in Epidemiology and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines.

13The database search yielded 636 records after de-duplication, which were screened on title/abstract level for eligibility (Figure 1). Sixteen potentially eligible articles were screened on full-text level, and 3 were excluded (Figure 1). Thirteen studies were included (Table 1). There were 5 longitudinal studies, 5 cross-sectional studies, 2 case–control studies, and 1 ecologic study. Two studies were on type 1 diabetes; 3 studies on gestational diabetes (GDM), and 8 studies on T2DM. Seven non-ecological studies on T2DM were selected for quantitative synthesis (with the exclusion of ). Air pollution estimates from these studies were based on land-use regression, kriging, and satellite-derived estimates. All studies were conducted in Europe or North America. Tables 1 and 2 and Supplemental Material, Table S1, provide an overview of the 13 eligible studies. Table 3 summarizes the data reported in the studies synthesized in meta-analyses.

14In the Supplemental Material, Table S2 provides an overview of potential sources of bias and how they were assessed by the 13 studies. These are discussed in detail below.

15Bias due to outcome assessment. As shown in Table 2, some studies relied on self-reported, physician-diagnosed DM, whereas others linked participants to established databases to identify cases. Additional steps were taken by some studies with self-reported outcomes to test the validity of the DM diagnosis. These steps included sending a follow-up questionnaire with the same questions about diabetes and confirmation from medical records provided by physicians. further tested participants who did not report physician-diagnosed diabetes, to identify undiagnosed cases.

16Bias due to exposure assessment. The reviewed studies used different approaches to assess exposure of participants to air pollution, including modeled concentrations of various particulate matters, nitrogen oxides (NOx), sulfates, ozone, and various proxies to estimate traffic-related pollution, with varying buffer levels. The studies are also heterogeneous with regard to the lag time considered for exposure assessment. Only the Danish cohort assessed the impact of different lag times, albeit with little evidence for substantial differences in effects (see Supplemental Material, Table S1). In the absence of a biological basis for the latency between exposure and diagnosis of diabetes, different lag times should be tested. Overall, the diversity of exposure measurement makes it difficult to compare the reported effect estimates across these studies.

17Bias due to confounder adjustment. Indoor air pollution and smoking. Beyond adjustment for basic DM risk factors at baseline (see Supplemental Material, Table S2), also adjusted for environmental tobacco smoke (ETS), indoor heating with fossil fuels, as well as occupational exposure to dust, fumes and extreme temperatures; also adjusted for ETS. One study done in children considered ETS exposure.

18Demographics, physical activity, and dietary factors. The longitudinal studies uniformly adjusted for age, body mass index (BMI), and sex (when study population includes both sexes). The studies on women did not adjust for dietary factors, and all longitudinal studies but one adjusted for alcohol consumption and physical activity (see Supplemental Material, Table S1). The other studies assessed confounding by age and BMI except the case–control studies, which did not consider the children’s BMI in their models. The GDM studies mostly considered maternal alcohol consumption (but not dietary factors) whereas the cross-sectional T2DM studies did not consider either factor (see Supplemental Material, Table S1).

19Socioeconomic status. There was a uniform adjustment for socioeconomic status in all studies, although on different scales. At the individual level, educational attainment as a socioeconomic determinant was most commonly used across studies, and a few studies additionally considered household income and ethnicity (see Supplemental Material, Table S1). Few studies considered spatial socioeconomic confounding in forms of unemployment rate, urban/rural residence, neighborhood income and neighborhood socioeconomic status score (see Supplemental Material, Table S1). Overall, there was sufficient consideration for individual-level socioeconomic status, but the insufficient control of area-level socioeconomic status may increase the risk of bias.

20Co-morbidities. Some co-morbidities associated with diabetes may also be associated with air pollution. These co-morbidities may include hypertension, myocardial infarction, stroke, asthma, and chronic obstructive pulmonary disease. The longitudinal studies considered some of these co-morbidities (see Supplemental Material, Table S1). Participants with co-morbidities were not excluded from any T2DM study.

21Effect modification. Several studies reported stronger effects in women compared with men. Other subgroups reported with potentially increased susceptibility include subjects with low education, COPD, asthma, higher waist-to-hip ratio, and higher level of subclinical inflammation, nonsmokers, and subjects < 50 years or > 65 years of age (see Supplemental Material, Table S1). No study assessed interaction between different air pollutants, air pollutants and noise, or interaction between air pollutants and genetic polymorphisms.

22Loss to follow-up. Losses to follow-up and healthy survivor bias present common problems in epidemiological studies. reported a loss of < 10% in both studied cohorts over 20 years of follow-up, and reported < 20% loss of cohort over 10 years of follow-up. The other longitudinal studies did not report losses to follow-up. None of the studies included sensitivity analyses to estimate the effect of the healthy survivor bias.

23Publication bias. Although selective reporting and publication bias cannot be ruled out, considering a high probability that negative findings will not be published, we found no indication for such sources of bias (p-value of Egger’s test > 0.2). Some studies reported negative findings. However, most studies had several markers of air pollution available, and it remains unclear if some markers have been measured but not reported, so some selective reporting may have occurred.

24Meta-analysis of studies reporting the association of air pollution and risk of T2DM. Results of seven studies reporting on risk of T2DM [three on particulate matter with diameter ≤ 2.5 μm (PM2.5) and four on nitrogen dioxide (NO2)] were considered for quantitative synthesis. All studies synthesized for PM2.5 were longitudinal. For NO2, two were longitudinal and two were cross-sectional.

25The pooled relative risks of T2DM per 10-μg/m3 increase in exposure to PM2.5 (Figure 2) and NO2 (Figure 3) were 1.10 (95% CI: 1.02, 1.18) and 1.08 (95% CI: 1.00, 1.17), respectively. The effect was more pronounced in females than in males [NO2: 1.15 (95% CI: 1.05, 1.27) vs. 0.99 (95% CI: 0.93, 1.07); PM2.5: 1.14 (95% CI: 1.03, 1.26) vs. 1.04 (95% CI: 0.93, 1.17), respectively] per 10-μg/m3 increase in exposure. The relative risks were similar across all sensitivity analyses (Table 4). We observed substantial statistical heterogeneity with NO2 studies (Table 4). Egger’s test was consistently > 0.2 (p-value) in all cases.

26In this systematic review, we considered 13 studies on different types of diabetes. The identified epidemiological evidence is highly diverse: Levels, timing, and assessment of exposure varied, as did the outcome definitions, measures of association, and degree of confounder control. The studies included persons with different age ranges and settings, and some populations included only women. Although there is a risk of bias, the results of the meta-analyses indicate a positive association between traffic-related air pollution and T2DM.

27Pathophysiologic mechanisms of DM–air pollution association. There is strong evidence supporting the role of inflammation in T2DM. Chronic activation of inflammatory mechanisms can contribute to chronic insulin resistance and subsequent T2DM. Air pollution has been shown to be inflammatory. Its potential mechanisms in mediating T2DM include pulmonary and systemic inflammation, directly releasing cytokines, alterations in glucose homeostasis through defective insulin signaling in tissues, immune cells activation in visceral adipose tissues potentiating inflammation, and endoplasmic reticulum stress in the lung and liver in relation with hepatocyte and alveolar cells. PM2.5 also acts as a hypothalamic stressor, inducing peripheral inflammation and abnormalities in glucose metabolism. PM2.5 was also shown to mediate dysfunctional brown adipose and mitochondrial tissues, which is one of the systemic pathologies in T2DM.

28demonstrated that exposure to air pollution [PM ≤ 10 μm (PM10) and ozone] exposure leads to alteration in blood pressure, blood lipids, and hemoglobin A1c, a marker of blood glucose control. found positive associations between exposure to PM10, NO2, and insulin resistance among children in Iran. later found a positive association between residential proximity to traffic, particulate matter (PM10), NO2, and risk of insulin resistance [homeostatic model assessment (HOMA-IR)] among children who were part of a birth cohort in Germany. Exposure to traffic-related air pollution is also associated with impaired glucose tolerance in pregnancy. Experimental evidence also exists for the association of air pollution and type 1 diabetes (T1DM). Ozone is known to alter T-cell dependent immune response, predisposing to autoimmune diseases. It may also damage the beta cells of the pancreas possibly as a result of pulmonary reactive oxidative species production and oxidative stress, leading to reduced insulin secretion. Together with sulfate, ozone may have apoptotic properties on the beta cells. The use of antioxidant prophylaxis for T1DM also points to the possibility of oxidative or inflammatory mechanisms in T1DM.

29Strengths and limitations. Although we applied a very broad search strategy and accepted any study design, there are few published studies on the association of air pollution with T1DM or GDM. In addition, some studies did not allow distinguishing adult T1DM from T2DM. Only three of the seven synthesized studies explicitly analyzed the T2DM risk. However, because > 90% of adult diabetes diagnoses are T2DM, this is unlikely to substantially affect the conclusions. Overall, the available data are not sufficient to evaluate associations with these diabetes types.

30Our analysis on the association with T2DM was based on results from primary studies with unclear to high risk of bias and high diversity among the included studies. We took this into account by using effect estimates modeled to participants’ residences, converting all effect estimates to a comparable unit (per 10 μg/m3 of exposure), stratifying analyses by sex, including only longitudinal studies, and performing other sensitivity analyses.

31The high diversity among the studies was reflected in our observation of substantial heterogeneity in the meta-analysis for NO2 (Table 4), which synthesized longitudinal and cross-sectional data. This was not observed for PM2.5, for which all studies were longitudinal. However, the number of studies was too small to further analyze this heterogeneity.

32Prospects. Future studies should report scales of exposure assessment (pollutant quantification and traffic exposure proxies) that allow direct comparisons with existing evidence. It would be important to apply comparable models in assigning exposure to participants. Ideally, traffic distance measures should be replaced by objective particle concentration measures and models of near-road traffic-related pollutants such as ultrafine particles of elemental carbon. Also, it would be important to consider various time lags for exposure.

33The studies on T1DM found associations with ozone and sulfates. These pollutants can be included in the future models for T2DM, because pollutants usually occur together in different proportions. Carbon monoxide, lead, oxidative metals, volatile organic compounds, and polycyclic aromatic hydrocarbons are other traffic-related pollutants that may be more deleterious to health but have been given less consideration.

34Adjusting for noise exposure is also essential because air pollution and noise can be correlated and share health effects. recently reported a positive association between road-traffic noise and incident diabetes, and another large meta-analysis of 10 epidemiologic studies by found that both quality and quantity of sleep, which are related to noise, were significant predictors of the risk of T2DM. Consideration of noise is thus necessary in assessing the health effects of air pollution.

35Also, socioeconomic variables should be adjusted on the spatial scale, apart from individual-level adjustment. Consideration for this spatial confounding is necessary when individual differences in health outcome are associated with neighborhood characteristics such as neighborhood socioeconomic status. It is crucial that studies on diabetes risk consider established diabetes risk factors including obesity, physical activity, and nutrition. Active and passive smoking should be considered when assessing the effect of air pollution. Lack of information on these creates a high risk for bias.

36Other forms of bias such as the healthy survivor effect should be taken into account, especially in longitudinal studies. demonstrated associations between diabetes mortality and NOx exposure; thus, diabetes patients exposed to air pollution could die and no longer participate, resulting in incorrect estimates of association if mortality was not taken into consideration.

37No included study on this topic was done in developing countries. For generalizability of evidence, research should be extended to developing countries where air pollution (including indoor) is high. This could also help in understanding effects of different air pollution compositions. Indoor air pollution is also associated with diabetes as well as cardiovascular diseases and is highly prevalent in developing nations.

38Considering the ambiguity in dose–response relationship in air pollution studies, future studies should assess air pollution diabetes association in a dose–response manner. This will help in identifying the point in the dose spectrum where control will yield the most benefits for health policy.

39Overall, the existing evidence indicates a positive association of air pollution and T2DM risk, although there is high risk of bias. High-quality longitudinal studies are needed (taking into consideration sources and composition of air pollution as well as biomarkers) to improve our understanding of this association.